Literature DB >> 25877835

NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

José Berciano1, Antonio García, Kristien Peeters, Elena Gallardo, Els De Vriendt, Ana L Pelayo-Negro, Jon Infante, Albena Jordanova.   

Abstract

The purpose of the study was to describe a pedigree with NEFL E396K mutation associated with a novel dominant intermediate Charcot-Marie-Tooth disease (DI-CMT) phenotype. The pedigree comprised four patients over two generations, aged between 35 and 59 years, who have been serially evaluated since 1993. Their clinical picture was characterized by pes cavus, sensorimotor neuropathy and spastic gait. Both older patients showed ascending leg weakness to involve pelvic musculature. CMT neuropathy score ranged from 14 to 26 (moderate to severe disease). Electrophysiology showed uniform nerve conduction slowing in the intermediate range, both in distal and proximal nerve segments. Multimodal evoked potential and blink reflex studies revealed abnormalities indicative of central sensorimotor pathway dysfunction. On imaging studies of lower-limb musculature, there was massive atrophy of intrinsic foot muscles and to a lesser degree of calves and thighs predominating in muscles innervated by tibial and sciatic nerves. In both patients exhibiting waddling gait, there was atrophy of pelvic muscles mainly involving gluteus medius, gluteus minimus and piriformis. We conclude that NEFL E396K mutation may manifest with a novel DI-CMT phenotype, characterized by simultaneous involvement of the peripheral and central nervous system.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877835     DOI: 10.1007/s00415-015-7709-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  54 in total

1.  Electromyographic tendon reflex recording: An accurate and comfortable method for diagnosis of charcot-marie-tooth disease type 1a.

Authors:  Antonio García; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; Francisco M Antolín; José Berciano
Journal:  Muscle Nerve       Date:  2015-05-14       Impact factor: 3.217

2.  Computed tomography of the skeletal musculature in Becker-type muscular dystrophy and benign infantile spinal muscular atrophy.

Authors:  M de Visser; B Verbeeten
Journal:  Muscle Nerve       Date:  1985-06       Impact factor: 3.217

3.  Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E.

Authors:  Hailian Shen; Devin M Barry; Jeffrey M Dale; Virginia B Garcia; Nigel A Calcutt; Michael L Garcia
Journal:  Hum Mol Genet       Date:  2011-04-14       Impact factor: 6.150

4.  Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings.

Authors:  Pankaj B Agrawal; Mugdha Joshi; Nicholas S Marinakis; Klaus Schmitz-Abe; Pedro D S C Ciarlini; Jane C Sargent; Kyriacos Markianos; Umberto De Girolami; David A Chad; Alan H Beggs
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

5.  Charcot-Marie-Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene.

Authors:  Isabel Banchs; Carlos Casasnovas; Jordi Montero; Victor Volpini; Juan Antonio Martínez-Matos
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

6.  Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation.

Authors:  Raul Perez-Olle; Conrad L Leung; Ronald K H Liem
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

7.  The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies.

Authors:  R Madrid; W G Bradley; C J Davis
Journal:  J Neurol Sci       Date:  1977-05       Impact factor: 3.181

8.  Reliability and validity of the CMT neuropathy score as a measure of disability.

Authors:  M E Shy; J Blake; K Krajewski; D R Fuerst; M Laura; A F Hahn; J Li; R A Lewis; M Reilly
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

Review 9.  Intermediate Charcot-Marie-Tooth disease.

Authors:  Lei Liu; Ruxu Zhang
Journal:  Neurosci Bull       Date:  2014-10-17       Impact factor: 5.203

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  10 in total

1.  Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E.

Authors:  E Villalón; M R Jones; C Sibigtroth; S J Zino; J M Dale; D S Landayan; H Shen; D D W Cornelison; M L Garcia
Journal:  Genes Brain Behav       Date:  2016-10-11       Impact factor: 3.449

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2.

Authors:  Alessia Peretti; Maud Perie; Didier Vincent; Françoise Bouhour; Klaus Dieterich; Martial Mallaret; Fanny Duval; Cyril Goizet; Raul Juntas-Morales; Laurent Magy; Guilhem Solé; Sylvain Nollet; Adeline Not; Sarah Léonard-Louis; Bruno Francou; Eric Leguern; Anne-Sophie Lia; Corinne Magdelaine; Philippe Latour; Tanya Stojkovic
Journal:  Eur J Hum Genet       Date:  2019-04-17       Impact factor: 4.246

4.  Molecular characterization of Turkish patients with demyelinating Charcot-Marie-Tooth disease.

Authors:  Taner Karakaya; Ayberk Turkyilmaz; Gunes Sager; Rahsan Inan; Oguzhan Yarali; Alper Han Cebi; Yasemin Akin
Journal:  Neurogenetics       Date:  2022-05-13       Impact factor: 3.017

5.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

6.  Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.

Authors:  Adriana P Rebelo; Alexander J Abrams; Ellen Cottenie; Alejandro Horga; Michael Gonzalez; Dana M Bis; Avencia Sanchez-Mejias; Milena Pinto; Elena Buglo; Kasey Markel; Jeffrey Prince; Matilde Laura; Henry Houlden; Julian Blake; Cathy Woodward; Mary G Sweeney; Janice L Holton; Michael Hanna; Julia E Dallman; Michaela Auer-Grumbach; Mary M Reilly; Stephan Zuchner
Journal:  Am J Hum Genet       Date:  2016-03-31       Impact factor: 11.025

7.  Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease.

Authors:  Alejandro Horga; Matilde Laurà; Zane Jaunmuktane; Nivedita U Jerath; Michael A Gonzalez; James M Polke; Roy Poh; Julian C Blake; Yo-Tsen Liu; Sarah Wiethoff; Conceição Bettencourt; Michael Pt Lunn; Hadi Manji; Michael G Hanna; Henry Houlden; Sebastian Brandner; Stephan Züchner; Michael Shy; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-05-13       Impact factor: 10.154

Review 8.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

9.  Cryptic amyloidogenic elements in mutant NEFH causing Charcot-Marie-Tooth 2 trigger aggresome formation and neuronal death.

Authors:  Arnaud Jacquier; Cécile Delorme; Edwige Belotti; Raoul Juntas-Morales; Guilhem Solé; Odile Dubourg; Marianne Giroux; Claude-Alain Maurage; Valérie Castellani; Adriana Rebelo; Alexander Abrams; Stephan Züchner; Tanya Stojkovic; Laurent Schaeffer; Philippe Latour
Journal:  Acta Neuropathol Commun       Date:  2017-07-14       Impact factor: 7.801

10.  Phenotypic heterogeneity in patients with NEFL-related Charcot-Marie-Tooth disease.

Authors:  Hye Jin Kim; Sang Beom Kim; Hyun Su Kim; Hye Mi Kwon; Jae Hong Park; Ah Jin Lee; Si On Lim; Soo Hyun Nam; Young Bin Hong; Ki Wha Chung; Byung-Ok Choi
Journal:  Mol Genet Genomic Med       Date:  2022-01-19       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.